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Background: Although the development of early-onset dementia is a radical and invalidating experience for both
patient and family there are hardly any non-pharmacological studies that focus on this group of patients. One type
of a non-pharmacological intervention that appears to have a beneficial effect on cognition in older persons
without dementia and older persons at risk for dementia is exercise. In view of their younger age early-onset
dementia patients may be well able to participate in an exercise program. The main aim of the EXERCISE-ON study
is to assess whether exercise slows down the progressive course of the symptoms of dementia.
Methods/Design: One hundred and fifty patients with early-onset dementia are recruited. After completion of the
baseline measurements, participants living within a 50 kilometre radius to one of the rehabilitation centres are
randomly assigned to either an aerobic exercise program in a rehabilitation centre or a flexibility and relaxation
program in a rehabilitation centre. Both programs are applied three times a week during 3 months. Participants
living outside the 50 kilometre radius are included in a feasibility study where participants join in a daily physical
activity program set at home making use of pedometers. Measurements take place at baseline (entry of the study),
after three months (end of the exercise program) and after six months (follow-up). Primary outcomes are cognitive
functioning; psychomotor speed and executive functioning; (instrumental) activities of daily living, and quality of
life. Secondary outcomes include physical, neuropsychological, and rest-activity rhythm measures.
Discussion: The EXERCISE-ON study is the first study to offer exercise programs to patients with early-onset
dementia. We expect this study to supply evidence regarding the effects of exercise on the symptoms of
early-onset dementia, influencing quality of life.
Trial registration: The present study is registered within The Netherlands National Trial Register (ref: NTR2124)
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Early-onset dementia (EOD; < 66 years) is less common
than late-onset dementia (LOD; > 65 years) [1]. In the
majority of studies, Alzheimer’s disease (AD) is the most
common subtype of EOD, followed by vascular dementia
(VaD) and frontotemporal dementia (FTD) [2-4]. The
clinical presentation of EOD, concerning cognitive and
behavioural disturbances, is quite heterogeneous and
depends on the neuropathological substrate [5-9]. EOD
places a large psychological and economical burden on
patients and caregivers because of the patients’ promin-
ent role in society (having young children, working) at
disease onset [10].
Despite the devastating impact of the disease, few
intervention studies focus on this specific group of
younger patients. Some pharmacological studies report
the inclusion of (a small subset of ) EOD patients
[11-13]. Non-pharmacological intervention studies, such
as exercise interventions studies, do not report to in-
clude EOD patients. Notably, there is an increasing
number of studies examining the effects of exercise on
cognitive and behavioural functioning in sedentary older
people [14], in patients in a very early stage of LOD
[15], and in patients in a moderate stage of LOD [16].
Most evidence of these studies points in the direction
of beneficial effects of exercise on cognition in the
aging population. Although, in view of their younger
age many EOD patients may be better able to perform
aerobic physical activity compared to healthy elders and
LOD patients, certain dementia characteristics such as
apathy may lead to sedentary and socially impoverished
lifestyles [17-19]. Indeed, a ‘frontal’ presentation, i.e.
symptoms as apathy and dysexecutive functioning, is
relatively common in EOD patients [9].
A brain region that plays a pivotal role in executive
functions is the prefrontal cortex [20]. Interestingly, es-
pecially those functions mediated by the prefrontal cor-
tex react positively to increased physical activity [21].
The functioning of other cortical areas such as the par-
ietal lobe also show a positive relationship with physical
activity [22]. Involvement of the prefrontal and parietal
cortices in exercise benefits stems form neuro-imaging
studies in older adults that show greater task-related ac-
tivity after an exercise intervention in regions of the
prefrontal and parietal cortices during an executive
function task [23]. It is noteworthy that particularly the
prefrontal cortex and the parietal lobe are vulnerable in
EOD [24,25] and may therefore offer a potentially ap-
propriate venue for intervention. Furthermore, EOD
patients are relatively young and suffer from less phys-
ical inconveniences compared to LOD patients [26]
which makes participation in an intensive exercise pro-
gram feasible and may result in larger benefits of the
intervention [27].The earlier mentioned positive effects of exercise com-
bined with the characteristics of EOD patients, makes the
lack of studies examining the effects of physical activity in
the EOD population a remarkable observation. An elabor-
ate description of the theory behind this observation is
described in our review, also including a brief summary of
part of the present study protocol [28]. In the present
manuscript we present the detailed description of the en-
tire protocol. This study is the first to investigate the exer-
cise effects on cognition and behaviour in EOD patients.
In the “EXERcise and Cognition In Sedentary adults with
Early-ONset dementia study” (EXERCISE-ON study),
three different exercise programs are offered to persons
with EOD: an aerobic exercise program in a rehabilitation
centre, a flexibility and relaxation program in a rehabilita-
tion centre and a daily physical activity program at home
using pedometers (for a description see section Interven-
tions). The present study is divided into two parts: a ran-
domized controlled trial (RCT) and a feasibility study. The
main aim of this study is to assess, making use of an RCT
design, whether exercise slows down the progressive
course of the symptoms of dementia, with respect to cog-
nition, in particular psychomotor speed and executive
functioning, and (instrumental) activities of daily living ((i)
ADL), and may subsequently lead to better quality of life
and less caregiver burden. In addition, a feasibility study is
conducted to evaluate whether a physical activity program
offered at home using pedometers can bring positive
effects for EOD patients and their caregivers.
Methods/Design
Study design
This study consists of two parts. The main study is
designed as a randomized controlled trial with one hun-
dred EOD patients. In addition a feasibility study will be
conducted with fifty EOD patients (Figure 1).
Participants
This study will include persons with a diagnosis of EOD:
AD, VaD, FTD or other types of dementia. Participants
will be recruited primarily in the Alzheimer centre of the
VU University medical centre (VUmc) in Amsterdam,
the Netherlands. Secondarily, participants will be
recruited through affiliate memory clinics. A careful
screening process, including medical history, physical,
neurological, and neuropsychological examination as well
as laboratory tests, electroencephalogram (EEG) and
magnetic resonance imaging (MRI), will lead to the iden-
tification of patients with EOD. Diagnoses are made
based on a multidisciplinary consensus team conference,
according to the clinical criteria of the Diagnostic and
Statistical Manual of Mental Disorders-IV-TR (DSM-IV-
TR) [29], on the National Institute of Neurological Disor-
ders and Stroke Alzheimer’s Disease and Related
General population
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Figure 1 Trial design.
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AD [30]; and on the National Institute of Neurological
Disorders and Stroke-Association Internationale pour la
Recherche et l'Enseignement en Neurosciences (NINDS-
AIREN) for VaD [31]. Initially participants are recruited
by a neurologist during a clinic visit where the patient,
caregiver, and other family members are informed of the
diagnosis. After provisional consent the study is
explained (verbally and by use of printed material) by the
principal investigator (AH), after which formal written
consent is obtained.
Inclusion criteria are the following: 1) Diagnosis of EOD
(onset of complaints < 66 years) (among others: AD, VaD,
FTD); 2) Relatively early stage of dementia (Mini Mental
State Examination (MMSE) score >15 [32]); 3) Primarycaregiver available. Participants will be excluded from par-
ticipation when they 1) are wheelchair-bound; 2) are diag-
nosed with a neurodegenerative disease that primarily
results in motor impairments, such as Parkinson's disease;
3) are diagnosed with serious cardiovascular disease, such
as heart failure; 4) have a history of substance abuse; 5)
had a head injury involving loss of consciousness greater
than 15 minutes; 5) have a history of major psychiatric ill-
ness (e.g. personality disorder, schizophrenia); 6) have se-
vere visual problems; 7) have severe hearing problems; 8)
have insufficient proficiency of the Dutch language.
Randomization
After obtaining written informed consent and comple-
tion of the baseline measurement, patients are assigned
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planned to randomize patients in one of three exercise
programs, with an allocation ration of 1:1:1. However,
during the pilot study travel distance to the rehabilita-
tion centres appeared to be a restraint for many patients
(even when patients were brought with taxis). The
randomization procedure had to be adjusted. Patients
who are living within 50 kilometres of one of the partici-
pating rehabilitation centres are randomly assigned to ei-
ther the aerobic exercise program or the flexibility and
relaxation exercise program. The allocation ratio is 1:1.
To ensure the allocation ratio block randomization is
used (block size is 4). Randomization is provided by
e-mail. An anonymous list with identification numbers
is sent to an independent researcher who is blinded to
the identity of the patients. This independent researcher
keeps the randomization list. Patients living outside a
50 kilometre radius of one of the rehabilitation centres
are included in the daily physical activity program at
home using pedometers.
Interventions
Patients living within a radius of 50 kilometres of one of
the rehabilitation centres are randomly assigned to one
of the following programs:
Aerobic exercise program in a rehabilitation centre
This aerobic exercise program aims to improve the car-
diorespiratory fitness of the participants. Activities con-
sist of a warming-up, a core activity, i.e. cycling on a
cycling ergometer, and a cooling down. The program
endures three months, takes place three times a week,
and is build up in duration and intensity [33]. Group size
varies from 2 to 5 participants. This program is guided
by a physical therapist (JB).
Flexibility and relaxation program in rehabilitation centre
The setting of this program is the same as for the aerobic
exercise program (duration, frequency, group size, rehabili-
tation centre, and physical therapist). The difference is in
the activities and the intensity of the program. Activities
consist of stretching and toning exercises in combination
with relaxation exercises. No build up is used.
Patients living outside the 50 kilometre radius from
one of the rehabilitation centres are included in the fol-
lowing program:
Daily physical activity program at home using pedometers
This program takes place at the participant’s home. The
program is based on the COACH method [34], devel-
oped by the interfaculty Centre for Human Movement
Sciences of the University of Groningen (Netherlands)
and the Centre for Movement and Research (CBO),
Groningen (Netherlands). The COACH method is anevidence-based method to stimulate sedentary indivi-
duals to enhance physical activity participation in daily
life, using “exercise counselling”. The exercise counsel-
ling is focused on intrinsic motivation [35], since this
type of motivation is predominantly related to sedentari-
ness [36] and is often disturbed in patients with brain
damage [37]. Patients develop a benchmark for physical
activity in several phases. Using 3 interviews, following
motivational interviewing [38] and goal setting techni-
ques [39,40], the participant’s attitude towards physical
activity is discussed and changed if necessary. The inter-
views are given by a neuropsychologist (in training).
Setting
Both the aerobic exercise program and the flexibility and
relaxation program are given in two rehabilitation centres
in the Netherlands (i.e. Reade, hospital Amstelland,
Amstelveen; department of rehabilitation, Jeroen Bosch
hospital,’s Hertogenbosch). The third exercise program
(pedometer) is offered nation-wide at the patients’ homes.
Measurements and procedures
Each participant will undergo three measurements: base-
line measurement (entry of the study, prior to
randomization), post measurement (end of the exercise
program, three months after baseline measurement), and
follow-up measurement (six months after baseline meas-
urement). A measurement consists of a neuropsycho-
logical examination during approximately 2 hours.
Thoroughly trained master students Clinical Neuro-
psychology, blinded to group allocation will administer
the tests. In the week following the neuropsychological
examination the participants wear a pedometer and an
actiwatch activity monitor for one week. Participants
that are able to visit one of the rehabilitation centres also
receive a physical examination during 30 minutes.
Primary outcome measures
1. Cognitive functioning
Alzheimer’s Disease Assessment Scale (ADAS)-COG
[41]. The ADAS-COG is designed to evaluate
cognitive disorders in persons with AD. The
ADAS-COG is often used in clinical trials for
dementia [42,43].
2. Psychomotor speed/executive functioning
Trail Making Test (TMT) [44]. The TMT consists of
two parts. Part A gives a measure for psychomotor
speed. The more complex Part B gives an indication
of cognitive flexibility, which is a part of executive
functioning.
3. (Instrumental) activities of daily living ((i)ADL)
Disability Assessment for Dementia (DAD) [45]. To
gain insight in the (i)ADL of participants, the DAD
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informant-report questionnaire specifically designed
for persons with a (beginning) dementia. The DAD
is administered to the caregiver and provides
information with respect to how the patient
performs (i)ADL’s and whether he/she is taking
initiative to do things.
4. Quality of life
The Dementia-Quality of Life (D-QOL) [46] is a
valid instrument to assess the quality of life in
persons with a mild to moderate stage of dementia
[47]. The D-QOL is a self-report questionnaire and
consists of propositions in 5 subscales: self-esteem,
positive effect, negative effect, feelings of belonging,
and enjoying the environment.
Secondary outcome measures
Physical measures
Physical fitness is assessed using the Åstrand cycle test
[48], which is a submaximal measure of fitness and is
used to estimate the maximal oxygen uptake (VO2max).
Walking speed is measured using the 6 Minutes Walk
Test [49]. Balance and strength of the lower extremities is
measured by the Sit to Stand Test [50]. Finally, the level
of physical activity (steps/day) is assessed using a pedom-
eter (OMRON HJ-113) [51,52]. Participants are also asked
to report their level of physical activity during the last
week. This is assessed using a self-report questionnaire,
the Physical Activity Scale for the Elderly (PASE) [53].
Neuropsychological measures
An extensive neuropsychological battery is administered.
Regarding episodic memory the “Face Recognition” from
the Rivermead Behavioural Memory Test (RBMT) [54] is
used to measure face recognition. Short term memory is
measured using the “Digit span forwards”, working mem-
ory using the “Digit span backwards” from the Wechsler
Adult Intelligence Scale – Revised (WAIS-R) [55]; Word
fluency is assessed using “category fluency” (animals and
occupations) from the Groninger Intelligence Test (GIT)
[56]; The Stroop Colour Word Test [57] short version is
used to measure interference and inhibition. Coding, psy-
chomotor-, and processing speed is measured using the
subtest “Symbol substitution” from the (WAIS-R) [55,58].
Furthermore, visuospatial capacity is assessed by the
“Perceptual closure” subtest from the GIT [56]. Finally,
self-efficacy is measured using a self-report question-
naire: General Self-efficacy scale (GES): Dutch version
[59].
Rest-activity rhythm
The rest-activity rhythm is assessed using the Actiwatch
activity monitor; Cambridge Neurotechnology Ltd.,
Cambridge, Great Britain [60].Demographic and control variables
At baseline, demographic information, i.e. age, sex,
educational attainment (using the system of Verhage,
ranging from 1 (low) to 7 (high) [61]), diagnosis of de-
mentia, number of years since diagnosis, and currently
prescribed medications will be collected. To determine
whether there has been a change in subjective physical
functioning and in the amount of encouragement
needed to start exercising several questions are asked
during recruitment. Outcome measures will also be con-
trolled for co-morbid medical conditions (medical
chart), depressive symptoms: Centre for Epidemiologic
Studies Depression Scale (CES-D) [62-64], and Apolipo-
protein E (ApoE) genotype [65,66], in view of possible
moderating effects on treatment outcome.Statistical analysis
In the statistical analysis an intention-to-treat analysis
will be performed in order to minimize bias [67]. Differ-
ences in the outcome measures between the aerobic ex-
ercise program and the flexibility and relaxation
program on the three measurement moments will be
analysed using a Linear Mixed Model (LMM) with con-
trasts. Time and treatment condition will be considered
as a within-subjects and a between-subjects variable re-
spectively. To analyse possible effects of the daily phys-
ical activity program at home using pedometers also a
LMM is used, with time as within-subjects variable.
Post-hoc analyses will be conducted to differentiate be-
tween persons who were physically active and persons
who were physically inactive, based on pedometer out-
comes on baseline measurement.Sample size
The sample size calculation (using G*power [68]) is
based upon two meta-analyses concerning studies in
which the effects of physical training on cognition was
investigated in either older adults with a cognitive dis-
order or dementia [69] or in healthy sedentary older
adults [14]. Summary effect sizes in these studies were
respectively Hedges’ g= 0.57 and g= 0.68, which are con-
sidered medium effect sizes. Since in the RCT part of
the present study the control group receives an interven-
tion existing of flexibility and relaxation exercises, in
contrast to a control group who does not perform any
physical activity, we assume a small effect size instead of
a medium effect size (f= .1). For 80 % power, the sample
size requirement (using a 5 % significance level) is 82
persons in total. Accounting for participants who with-
draw from the study, as is seen in other intervention
studies with healthy older adults [70] and patients with
dementia [16] the total study population is targeted at
100 participants.
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was used (f= .15), in order to avoid Type II errors. Keep-
ing the parameters equal to the situation above, the esti-
mated sample size is 38 persons. Accounting for
participants who withdraw from the study, the study
population for this part of the study is targeted at 50
persons.
Ethical and legal considerations
The protocol is reviewed and approved by the Extra-
mural Medicine institute (EMGO) which is part of the
Dutch School of Primary Care Research (CaRe) (ref:
WC2009-046). Ethical aspects of the protocol were
approved by the accredited Medical Review Ethics Com-
mittee (aMREC) of the VUmc (ref: 2009–220) according
to the Declaration of Helsinki (2008). The research has
been included in the general assessment and registration
form (ABR form) (ref: NL27426.029.09) and in The
Netherlands National Trial Register (NTR) (ref:
NTR2124).
Discussion
The EXERCISE-ON study will evaluate whether exercise
slows down the progressive course of the symptoms of
dementia in EOD patients. Characteristics of EOD
patients, such as apathy, loss of initiative, together with
their age and physique, make them good candidates for
a physical activity program.
 This study has several strengths. Despite the
devastating impact of EOD on the lives of patients
and their families, few specific treatments are
available for EOD patients. First of all, EOD patients
are dependent on facilities developed primarily for
elderly, and second of all, EOD patients are
underrepresented in scientific studies. Some
pharmacological studies report the inclusion of
(a small subset of ) EOD patients. To our knowledge
the present study is the first study that offers
exercise interventions to EOD patients. Another
strength is that the exercise programs are offered in
different settings. This is the first study that brings
patients suffering from dementia into a
rehabilitation setting involving the guidance of an
experienced physical therapist. In the rehabilitation
centres patients are exposed to fellow EOD patients.
Fellow patients can share experiences and tips,
which may help getting grip on the consequences of
a chronic disease [71]. The daily activity program is
offered at participants homes. Particular this setting
stimulates potential implementation in the future.
 A challenge in this study is the inclusion of a
sufficient number of participants. EOD is a rare
condition, the proportion of people with EOD variesbetween 7.3 % to 31 % in studies from Japan, the
UK, and the USA [4,10,72,73]. Furthermore, it is
expected that EOD patients have busier lives and are
involved in more activities in contrast to patients
suffering from dementia at an older age, similar to
healthy adults of middle and older age [74]. To
overcome this challenge we include multiple
rehabilitation centres and also offer a home-based
daily physical activity program to patients that are
not able to travel to one of the rehabilitation
centres.
In summary, the EXERCISE-ON study is an innovative
study examining possible beneficial effects of exercise on
symptoms, with respect to cognition, (i)ADL, and quality
of life, of EOD. Study results may contribute substantially
to care facilities for EOD patients. Furthermore, exercise
may offer a new set of coping skills for this patient group.
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